10/9/2026
FDA seeks input on ibogaine trials amid safety concerns
FDA's request for ibogaine trial proposals highlights cardiac risks and regulatory challenges.
Topic archive
psychoactive compounds
10 stories
10/5/2026
Psyence partners with Benuvia for ibogaine production
DEA-registered Benuvia to manufacture ibogaine for Psyence in the U.S.
10/5/2026
Psyence BioMed partners with Benuvia for US ibogaine production
Psyence BioMed collaborates with Benuvia to advance ibogaine manufacturing in the US.
10/2/2026
Ibogaine draws Americans to Mexico for costly psychedelic retreats
High-profile figures seek ibogaine for personal growth, despite U.S. restrictions.
9/22/2026
Presley Gerber's ibogaine treatment journey before his death
Model Presley Gerber sought ibogaine therapy in Mexico amid addiction struggles.
9/22/2026
Ibogaine treatment and the case of Presley Gerber
Presley Gerber's use of ibogaine highlights its controversial role in addiction treatment.
8/25/2026
Ibogaine research explores postpartum depression
New framework investigates ibogaine's potential in treating postpartum depression.
8/19/2026
Arizona funds $5M ibogaine study for brain injuries
Barrow Neurological Institute to explore ibogaine's potential for PTSD and brain injuries.
8/7/2026
Arizona funds $5M ibogaine trial for brain injury
Study explores ibogaine's potential for TBI, amid safety concerns and federal illegality.
7/29/2026
Texas begins state-led ibogaine research with federal support
The new program aims to explore ibogaine's potential in treating opioid addiction.